These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

564 related items for PubMed ID: 14517851

  • 1. Inhibition of advanced glycation end-products protects against retinal capillary basement membrane expansion during long-term diabetes.
    Gardiner TA, Anderson HR, Stitt AW.
    J Pathol; 2003 Oct; 201(2):328-33. PubMed ID: 14517851
    [Abstract] [Full Text] [Related]

  • 2. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: comparison of diabetes and galactosemia.
    Kern TS, Tang J, Mizutani M, Kowluru RA, Nagaraj RH, Romeo G, Podesta F, Lorenzi M.
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3972-8. PubMed ID: 11053301
    [Abstract] [Full Text] [Related]

  • 3. The effects of aminoguanidine on retinopathy in STZ-induced diabetic rats.
    Luo D, Fan Y, Xu X.
    Bioorg Med Chem Lett; 2012 Jul 01; 22(13):4386-90. PubMed ID: 22627042
    [Abstract] [Full Text] [Related]

  • 4. Effects of inhibition of glycation and oxidative stress on the development of cataract and retinal vessel abnormalities in diabetic rats.
    Agardh E, Hultberg B, Agardh C.
    Curr Eye Res; 2000 Jul 01; 21(1):543-9. PubMed ID: 11035534
    [Abstract] [Full Text] [Related]

  • 5. Microvascular basement membranes in diabetes mellitus.
    Tsilibary EC.
    J Pathol; 2003 Jul 01; 200(4):537-46. PubMed ID: 12845621
    [Abstract] [Full Text] [Related]

  • 6. A new advanced glycation inhibitor, LR-90, prevents experimental diabetic retinopathy in rats.
    Bhatwadekar A, Glenn JV, Figarola JL, Scott S, Gardiner TA, Rahbar S, Stitt AW.
    Br J Ophthalmol; 2008 Apr 01; 92(4):545-7. PubMed ID: 18211931
    [Abstract] [Full Text] [Related]

  • 7. Antioxidants and an inhibitor of advanced glycation ameliorate death of retinal microvascular cells in diabetic retinopathy.
    Yatoh S, Mizutani M, Yokoo T, Kozawa T, Sone H, Toyoshima H, Suzuki S, Shimano H, Kawakami Y, Okuda Y, Yamada N.
    Diabetes Metab Res Rev; 2006 Apr 01; 22(1):38-45. PubMed ID: 15892182
    [Abstract] [Full Text] [Related]

  • 8. The relationship of glycaemic level to advanced glycation end-product (AGE) accumulation and retinal pathology in the spontaneous diabetic hamster.
    Hammes HP, Wellensiek B, Klöting I, Sickel E, Bretzel RG, Brownlee M.
    Diabetologia; 1998 Feb 01; 41(2):165-70. PubMed ID: 9498649
    [Abstract] [Full Text] [Related]

  • 9. Advanced glycosylation end-products in experimental murine diabetic nephropathy: effect of islet isografting and of aminoguanidine.
    Nicholls K, Mandel TE.
    Lab Invest; 1989 Apr 01; 60(4):486-91. PubMed ID: 2496273
    [Abstract] [Full Text] [Related]

  • 10. Effects of angiotensin-converting enzyme inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy.
    Zheng Z, Chen H, Xu X, Li C, Gu Q.
    Exp Eye Res; 2007 Apr 01; 84(4):745-52. PubMed ID: 17303121
    [Abstract] [Full Text] [Related]

  • 11. Reduction of retinal albumin leakage by the antioxidant calcium dobesilate in streptozotocin-diabetic rats.
    Rota R, Chiavaroli C, Garay RP, Hannaert P.
    Eur J Pharmacol; 2004 Jul 14; 495(2-3):217-24. PubMed ID: 15249173
    [Abstract] [Full Text] [Related]

  • 12. Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.
    Kowluru RA.
    Life Sci; 2005 Jan 14; 76(9):1051-60. PubMed ID: 15607333
    [Abstract] [Full Text] [Related]

  • 13. Depletion of nitric oxide synthase-containing neurons in the diabetic retina: reversal by aminoguanidine.
    Roufail E, Soulis T, Boel E, Cooper ME, Rees S.
    Diabetologia; 1998 Dec 14; 41(12):1419-25. PubMed ID: 9867208
    [Abstract] [Full Text] [Related]

  • 14. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants.
    Kowluru RA, Odenbach S.
    Invest Ophthalmol Vis Sci; 2004 Nov 14; 45(11):4161-6. PubMed ID: 15505070
    [Abstract] [Full Text] [Related]

  • 15. Gene expression of receptor for advanced glycosylation end products and its modulation by aminoguanidine in diabetic kidney tissue.
    Huang Y, Lin S, Zhou J.
    Chin Med J (Engl); 1998 Aug 14; 111(8):698-704. PubMed ID: 11245022
    [Abstract] [Full Text] [Related]

  • 16. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
    Chang KC, Tseng CD, Wu MS, Liang JT, Tsai MS, Cho YL, Tseng YZ.
    Eur J Clin Invest; 2006 Aug 14; 36(8):528-35. PubMed ID: 16893374
    [Abstract] [Full Text] [Related]

  • 17. The protective effect of aminoguanidine on erectile function in diabetic rats is not related to the timing of treatment.
    Usta MF, Bivalacqua TJ, Koksal IT, Toptas B, Surmen S, Hellstrom WJ.
    BJU Int; 2004 Aug 14; 94(3):429-32. PubMed ID: 15291881
    [Abstract] [Full Text] [Related]

  • 18. Absence of degenerative changes in retinal and uveal capillary pericytes in diabetic rats.
    Tilton RG, LaRose LS, Kilo C, Williamson JR.
    Invest Ophthalmol Vis Sci; 1986 May 14; 27(5):716-21. PubMed ID: 3700020
    [Abstract] [Full Text] [Related]

  • 19. Calcium dobesilate attenuates vascular injury and the progression of diabetic retinopathy in streptozotocin-induced diabetic rats.
    Padilla E, Ganado P, Sanz M, Zeini M, Ruiz E, Triviño A, Ramírez AI, Salazar JJ, Ramírez JM, Rojas B, Hoz Rd, Tejerina T.
    Diabetes Metab Res Rev; 2005 May 14; 21(2):132-42. PubMed ID: 15386814
    [Abstract] [Full Text] [Related]

  • 20. C-peptide and retinal microangiopathy in diabetes.
    Chakrabarti S, Khan ZA, Cukiernik M, Zhang W, Sima AA.
    Exp Diabesity Res; 2004 May 14; 5(1):91-6. PubMed ID: 15198374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.